After all VS treatments, the population's PFS was 92.8 +/-1.5% at 5 years and 83.7% +/-2.9% at 10 years. The population's SH preservation at last follow-up was 34.2%. SAEs occurred in 4.7% of patients.
In the radiotherapy cohort of 136 patients, 17% had previous surgery (4 complete resection, 5 planned subtotal resection and 14 unplanned partial resection). 67% had single-fraction stereotactic radiosurgery and 33% had fractionated stereotactic radiotherapy. 7% (10/136) had progressive disease requiring salvage surgery. 18% had FND (HB grade 2 or more) at presentation. No patients had improvement in FND after RT and 17% had new or worsened FND after treatment. SAEs were: hydrocephalus requiring ventriculoperitoneal shunt 1.5% radionecrosis 0.7%, hospitalization for steroid myopathy 0.7% and death from complications of disease 0.7%.
In the surgical cohort of 206 patients, 8% had previous treatment (8 radiation, 9 surgery). The most common surgical approaches were retrosigmoid (89%) and translabyrinthine (6%). 2% had planned post-op RT and 12% had disease progression requiring salvage: 19 RT, 3 surgery, 2 unknown. 12% had FND at presentation. FND improved in 4.4% and worsened in 12.6% after surgery. SAEs were: increased intracranial pressure requiring external ventricular drain 2.9%, dural fistula requiring lumbar drain 1.5%, evacuation of hematoma 1.0%, and perioperative death 0.5%.
Conclusion
Multidisciplinary management of VS provides excellent disease control at a population level with hearing preservation in a minority of patients and a low risk of serious adverse events.
